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Abstract  
Cadmium (Cd), an environmental toxic pollutant affects many organs in human beings specially the liver and kidney. In this 
study, Cd (3 mg/kg body weight (b.w.)) was subcutaneously administered to rats for 3 weeks, which shows significantly 
(P<0.05) increase in the activities of serum transaminases, alkaline phosphatase and lactate dehydrogenase, with significant 
elevation of lipid peroxidation along with significant (P<0.05) decreased in the levels of antioxidants in the liver. Oral 
administration of silibinin (SB) at 80 mg/kg b.w. significantly normalized the activities of serum hepatic enzymes and reduced 
the levels of lipid peroxidation and also restored the antioxidant defense in the liver when compared to other doses of SB (20 
and 40 mg/kg b.w.). Histopathological analysis of liver was consistent with the biochemical findings. From this study we 
conclude the curative potential of SB against Cd- induced hepatic injury.    
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INTRODUCTION  
 
     Cadmium (Cd) a highly toxic metal which has been classified 
as human carcinogen by International Agency for Research on 
Cancer (Bertin and Averbeck, 2006). It is used in electroplating, paint, 
dyestuffs and mining industries and it is major threat to humans. In 
mammals, Cd targets the liver (Santos et al., 2004), brain (Shaikh 
and Tang, 1999), lungs (Horiguchi et al., 2000), gastrointestinal tract 
(Weisman, 1998) and kidney (El-Sharaky et al., 2007). Human 
beings are also exposed by various ways such as cigarette smoke, 
air pollution and food chain (Chen et al., 2007). Cd after entering into 
the body, it binds to albumin and erythrocytes in the blood and then it 
is transferred into tissues and organs, where it is bound to proteins of 
low molecular mass producing metallothioneins (George et al., 1996). 
The molecular mechanism that may be responsible for the toxicity of 
Cd involves oxidative stress disturbing the antioxidant defense 
system and by producing reactive oxygen species (ROS) (Thijssen 
et al., 2007) like hydrogen peroxide (H2O2), superoxide anion (O2.-), 
hydroxyl radical (OH.-), which increase lipid peroxidation (LPO), 
change intercellular stability, damage deoxyribonucleic acid (DNA), 
membranes and cell death (Stohs et al., 2001). More beneficial 
effects were documented for combined treatment with chelating 
agent and antioxidants against Cd-induced oxidative stress in rats 
liver (Tandon et al., 2003). 
     Flavonoids are phenolic compounds widely distributed in 
plants, which were reported to exert multiple biological effects, 
including antioxidant and free radical scavenging abilities (Slaterand 
Eakins., 1975; Bors and Saran, 1987; Ne`gre-Salvayre and Salvayre, 
1992). Flavonolignan silibinin (SB) (Fig. 1) is a major biologically 
active component of silymarin which are extracted from the seeds of 
milk thistle (Silybum marianum (L) gaertn). SB is present in 
numerous phytopreparations used in the prevention and treatment of 
various liver diseases and as protectants against a number of 
hepatotoxins (Flora et al., 1998) and mycotoxins. (Gallo et al., 2003). 
It possess multiple beneficial activities which are related to 
hepatoprotective (Ferenci et al ., 1989), metal chelating property 
(Pietrangelo, et al., 1995), effective antioxidant (Saller et al ., 2001), 
free radical-scavenging (Winterbourn, 2008), anticancer (Deep and 
Agarwal, 2007), chemoprotective (Comelli et al ., 2007), 
hypocholesterolemic (Skottova et al., 1999), neuroprotective (Kittur 
et al ., 2002) and estrogenic activity (Pliskova et al., 2008). 
     Eventhough the pharmacological properties of SB have been 
well established, the molecular mechanism of the antioxidative 
activity of SB and its derivative has not been systematically 
investigated and remains unclear. The active sites of SB is C-20 
hydroxyl and have been identified their essential role in the 
interaction with radicals. (Gyorgy et al., 1992).  
     The present study was designed to demonstrate the 
hepatoprotective activity of the SB against the potent heavy metal 
(Cd) toxin induced hepatotoxicity in rats. For this, we aimed to 
measure the hepatic marker enzymes such as aspartate amino 
transferase (AST), alanine amino transferase (ALT), alkaline 
phosphatase (ALP) and lactate dehydrogenase (LDH) and gamma 
gultamyl transferase (GGT). The prooxidant-antioxidant status of the 
liver was assessed by measuring the activities of the intracellular 
antioxidant enzymes such as superoxide dismutase (SOD), catalase 
(CAT), glutathione peroxidase (GPx) and glutathione -S- transferase 
(GST) and evaluating the levels of the ROS scavengers reduced 
glutathione ( GSH) and the levels of the Vitamin-C, Vitamin-E and 
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MATERIALS AND METHODS 
Chemicals  
 
     Silibinin, cadmium chloride and other fine chemicals were 
obtained from Sigma – Aldrich, Co. (St. Louis, Mo, USA). 
Commercial kits to estimate AST, ALT, ALP and LDH, were obtained 
from Agappe Diagnostics (I) Pvt. Ltd. (Kerala, India). All the other 




     Male albino Wistar rats of initial body weight 180-220 g were 
used in this experimental study. The rats were bred in the Central 
Animal House, Rajah Muthiah Medical College, Annamalai University 
(temperature 28 ± 2 °C; natural light-dark cycle). The rats had free 
access to drinking water and commercial standard pellet as diet (M/S. 
Pranav Agro Industries Ltd., Bangalore, India) and water ad libitum. 
The laboratory animal protocol used in this study was approved 
(Approval No: 610, 2009) by the Institutional Animal Ethical 
Committee (IAEC) at Annamalai University, Annamalainagar, India. 




The total rats were randomly divided into six groups of six rats in 
each. 
Group 1: Control rats (Vehicle treated) 
Group 2: Normal rats orally administrated with SB (80 mg/kg b.w. 
/day) dissolved in 0.1% Dimethyl Sulphoxide (DMSO) for 
3 weeks. 
Group 3: Normal rats were subcutaneously received Cd as 
cadmium chloride (3 mg/kg b.w. / day)   (Pari and 
Murugavel, 2005) in isotonic saline for 3 weeks. 
Group 4: Rats subcutaneously received Cd (3mg/kg bw/day) 
followed by oral administration of SB (20 mg/kg b.w. 
/day) in 0.1% DMSO for 3 weeks. 
Group 5: Rats subcutaneously received Cd (3mg/kg bw/day) 
followed by oral administration of SB (40 mg/kg b.w. 
/day) in 0.1% DMSO for 3 weeks. 
Group 6: Rats subcutaneously received Cd (3mg/kg bw/day) 
followed by oral administration of SB (80 mg/kg b.w. 
/day) in 0.1% DMSO for 3 weeks. 
     At the end of the experimental period, animals in different 
groups were sacrificed by decapitation under pentobarbitone sodium 
(60 mg/kg body weight) anaesthesia. Blood samples were collected 
for separation of serum by the centrifugation at 2000xg for 20 
minutes. The liver was dissected out, weighed and washed using 
chilled saline solution. Tissue was minced and homogenised (10%, 
w/v) in appropriate buffer (pH 7.4), and centrifuged (3000×g for 10 




Activities of serum marker enzymes 
 
     The activities of serum aspartate transaminase (AST), alanine 
transaminase (ALT), alkaline phosphatase (ALP) and lactate 
dehydrogenase (LDH) were assayed by spectophotometrically 
according to the standard procedures using commercially available 
diagnostic kits (Agappe Diagnostics (I) Pvt. Ltd., Kerala, India). 
Gamma glutamyl transferase (GGT,) activity was determined by the 
method of Rosalki et al. (1970) using γ-glutamyl-p-nitroanilide as 
substrate. 
 
Estimation of LPO  
 
     Lipid peroxidation (LPO) in liver was determined by 
measuring the levels of thiobarbituric acid reactive substances 
(TBARS) and lipid hydroperoxides (LOOH) by the method of Niehaus 
and Samuelsson (1968) and Jiang et al., (1992), respectively.  
 
Determination of antioxidant activities. 
 
     The level of reduced glutathione (GSH) in the liver was 
estimated by spectrophotometric method based on the reaction with 
Ellman’s reagent (19.8 mg dithionitrobenzoic (DTNB) in 100 ml of 
0.1% sodium citrate) according to Moron et al., (1979). Ascorbic acid 
(vitamin C) and α- tocopherol (vitamin E) concentrations were 
measured by the method of Omaye et al., (1979) and Desai, (1984) 
respectively. The activities of superoxide dismutase (SOD) (Kakkar 
et al., 1984), catalase (CAT) (Sinha, 1972), glutathione peroxidase 
(GPx) (Rotruck et al., 1973) and glutathione-S-transferase (GST) 
(Habig et al., 1974) were also measured in liver tissue homogenate 




     The liver tissue samples fixed for 48 hours in 10% formalin 
were dehydrated by passing successfully in a different mixture of 
ethyl alcohol - water, cleaned in xylene and embedded in paraffin. 
Sections of liver (5-6 mm thick) were prepared and then stained with 
hematoxylin and eosin dye (H&E), and mounted in neutral DPX 




     All data’s are expressed as mean ± SD of number of 
experiments (n=6). The statistical significance was evaluated by one-
way analysis of variance (ANOVA) using SPSS version 11.5 (SPSS, 
Cary, NC, USA), and the individual comparison were obtained by 
Duncans’ Multiple Range Test (DMRT). Values were considered 
statistically significant when P<0.05 (Duncan, 1957). 
 
RESULTS 
Biochemical analysis  
 
     Table 1 demonstrates the activities of serum hepatic enzymes 
namely AST, ALT, ALP, LDH and GGT and bilirubin in Cd and SB 
treated rats. The Cd-treated rats were showed significantly (P<0.05) 
increased in the activities of AST, ALT, ALP, LDH and GGT and 
bilirubin when compared to control rats. Oral administration of SB 
were significantly (P<0.05) normalized the levels of serum hepatic 
marker enzymes in a dose dependent manner. In this manner SB at 
80mg/kg b.w. was more effective when compared with other two 
doses (20 and 40mg/kg b.w.). There was no significant changes 
were found in control or SB alone treated groups. Hence, 80mg/kg 
b.w. dose was followed for the further studies.
 




Table 1. Effect of SB on Cd induced serum biochemical changes in control and experimental rats 
Values are mean ±SD for 6 rats in each group. a-e In each rows, means with different superscript letter differ significantly at p<0.05  
(DMRT).  Cadmium+ Silibinin (Cd + SB), aspartate amino transferase (AST), alanine amino transferase (ALT), alkaline phosphatase  
(ALP) and lactate dehydrogenase (LDH) and gamma gultamyl transferase (GGT).     
 
 
Table 2. Changes in the levels of lipid peroxidation markers in plasma and liver of control and experimental rats 
 
        
Values are mean ± SD for 6 rats in each group. a-c In each rows, means with different superscript letter differ significantly at p<0.05 (DMRT).   
Cadmium+ Silibinin (Cd + SB), thiobarbituric acid reactive substances (TBARS), lipid hydroperoxides (LOOH). 
 
Table 3. Changes in the levels of non enzymic antioxidants in plasma and liver of control and experimental rats 
 
 
     Protective effect of SB on Cd induced experimental 
peroxidative damage is shown in Table. 2. Hepatic and plasma LPO 
was enhanced after Cd intoxicated rats (P<0.05). Oral administration 
of SB therapy significantly inhibited LPO (P<0.05) and reduced the 
peroxidative stress in liver. 
     Effect of SB and Cd on enzymic antioxidants is shown in Fig. 
2, 3, 4, 5. Cd intoxication diminished the status of enzymic 
antioxidants by decreasing the activities of hepatic SOD, CAT, GPx 
and GST (P<0.05). Oral administration of SB restored the activities 
of SOD, CAT, GPx and GST (P<0.05) towards control. 
     Table 3 presents the non-enzymic antioxidant status in terms 
of   GSH, vitamin C and vitamin E. Cd intoxication significantly 
inhibited the activities of GSH, vitamin C and vitamin E (P<0.05). SB 
therapy enhanced the production of GSH, vitamin C and vitamin E 




     The histopathological studies of the liver in Cd-intoxicated rats 
showed microvesicular fatty change of hepatocytes and periportal 
inflammatory cell infiltration (Figure 2C), whereas the oral 
administration of SB to Cd-injected rats showed the reduction of fatty 
changes with mild portal inflammation in hepatocytes (Figure 2D). 
The control (Figure 2A) and SB alone (Figure 2B) treated rats 
showed normal architecture of the liver. 
 






Fig 2. (A) Shows histology of control rat liver architecture (400x), (B) Demonstrate the histology of SB (80 mg/kg) alone treated rat liver cells which appear near to normal 
(400x), (C) illustrate the Cd (3 mg/kg) alone treated rat histopathology which shows microvesicular fatty change of hepatocytes and periportal inflammatory cell infiltration 




     Cd- induced liver damage is well-documented, which involves 
changes in many biochemical and physiological process. The well-
established efficiency of flavonolignan in several invitro and invivo 
models showed the oxidative stress-mediated hepatocellular injury in 
experimental rats (Comelli et al., 2007). So we aimed to study its 
efficacy on Cd- induced hepatotoxicity in rats. 
     To assess the Cd toxicity in the chosen tissues through 
studying the changes of the biochemical profiles of certain vital 
hepatic enzymes activities (Sujatha et al., 1999).  AST and ALT 
which are the hepatic marker enzymes mainly elevated during 
hepatic injury. The functional state of the liver is indicated by the 
changes in the levels of AST and ALT in serum. ALP is a membrane 
bound enzyme and its alteration produce derangement in the 
transport of metabolites (Ahmed et al., 1999). LDH is an intracellular 
enzyme, is also an indicator for cell damage by elevation of LDH in 
serum (Kim et al., 2001). After Cd treatment the cell membrane is 
damaged, resulting in an increased release of functional enzymes in 
serum, which gives the indication of hepatic injury caused by Cd. 
Serum GGT, has been widely used as an index to assess liver 
dysfunction. Recent studies indicating that serum GGT might be 
useful in studying oxidative stress-related issues. The products of the 
GGT reaction may themselves lead to increased free radical 
production, particularly in the presence of iron (Lee et al., 2004). In 
Cd treated rats, the significant elevation of serum GGT might be 
related to increased oxidative stress induced by Cd. Oral 
administration of SB (80 mg/kg b.w.) significantly normalized the 
levels of serum hepatic enzymes in Cd-intoxicated rats, which 
indicate the interference of SB with Cd-induced alterations in cell 
membrane, that reduce the hepatic dysfunction and leakage of 
hepatic marker enzymes in blood. 
     Cd–induced oxidative damage has been established by 
increased LPO and decrease of antioxidant levels, which indicates 
the preventing from the oxidative damaged products (Kelley et al., 
1999). The observed increase in the level of TBARS and 
hydroperoxides in Cd toxicity is generally thought to be the 
consequence of increased production and liberation of tissue lipid 
peroxides, due to increased formation of free radicals as a result of 
Cd accumulation in the liver (Waisberg et al., 2003). Administration 
of SB to Cd-treated rats, significantly decrease lipid peroxides due to 
the ability of SB to scavenge the free radicals, suggesting the 
bioactivity of SB to directly react with various reactive oxygen 
species (ROS). The free radical scavenging property of SB has been 
already well established in experimental rats (Winterbourn, 2008).  
     As a result of Cd-toxicity, a remarkable diminution of tissue 
and circulating enzymic antioxidants such as SOD, CAT, GPx and 
GST are noticed (Casalino et al., 2002). After oral administration of 
SB (80mg/kg b.w.) to Cd-treated rats the level of enzymic antioxidant 
is significantly increased in the liver. SB inhibits the membrane LPO, 
which induce the expression of SOD in astrocytes (Dehmlow, 1996). 
The mechanism action of SB enhancing the level of GST 
simultaneously it increase the level of GSH (Zhao and Agarwal, 
1999).  
     In Cd exposed rats, a depletion of non-enzymic antioxidants 
in liver tissue, which includes GSH, vitamin C and vitamin E, have 
been observed (Pari and Murugavel, 2005).  The main route of Cd 
intoxication is exhaustion of glutathione and binding to the SH group 
of proteins. The first defense mechanism against Cd toxicity is 
provided by GSH, which efficiently binds with Cd via its free 
sulphydryl groups, and eventually become oxidized to oxidized 
glutathione (Valko, 2005). Vitamin C is a major preventive 
antioxidant in the cells and body fluids, which scavenges the free 
radicals and serves as a metabolic marker of Cd toxicity (Pharikal et 
al., 1988).  
     Vitamin E is a lipophilic antioxidant, which plays a crucial role 
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in detoxifying the free radicals developed through Cd induced 
oxidative damage in the liver. The diminution of sulphydryl assets 
seems to be an important mechanism for oxidative stress caused 
through indirect mechanism of Cd (Stoh and Bagchi, 1993). As a 
result of decrease in the levels of vitamin C and vitamin E which 
leads to increased susceptibility of the tissues to free radical damage 
through Cd intoxication (Sunitha, 2001). SB directly scavenges the 
free radicals through chelating Cd and moderates the expenditure of 
non-enzymic antioxidants endogenously. The thiol compounds 
possess antioxidant actions, which include reducing power and metal 
ion chelating effect, in addition it improved the alteration in the 
intracellular redox potential which in turn can regulate the activity of 
several transcription factors and it results in modulation of cellular 
functions (Sun and Oberley, 1996). In addition, the active sites of SB 
C-20 hydroxyl groups may contribute to improve the tissue thiol 
pools, which could be associated with a reduction of Cd-induced 
oxidative threat, and increased antioxidant status in SB 
administrated Cd-treated rats.  
     Chelation of Cd reduces the oxidative stress, reverses the 
antioxidant level and glutathione metabolizing enzymes activities due 
to the presence of hydroxyl groups in SB and it react with free 
radicals. 
     Along with the results of biochemical tests, the 
histopathological observations imply that Cd accumulation leads to 
serious changes in the histology of the liver, including microvesicular 
fatty change, inflammatory cell infiltration, focal necrosis and 
sinusoidal dilation, thus posing a health risk, which has been also 
reported previously (Tzirogiannis et al., 2004). Administration of SB 
reduced the histological alterations in the liver caused by Cd 
intoxication, which may be due to the chelation of Cd content in the 
treatment. In addition, SB administrated to Cd-intoxicated rats 
contributed to improve the antioxidant defense and depletion of Cd, it 
could be the reason for protection of liver architecture and functions, 
which compared with hepatic markers. 
     In conclusion, our study proposes that SB may play a 
beneficial role to reduce the toxic effects of Cd-induced damage in 
liver, which could be due to its antioxidant nature scavenge the free 
radicals and by metal chelating activities. Future studies are required 
to elucidate the specific mechanisms by which SB protect the Cd-
induced toxicity in experimental rats. 
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